Search results
OrthoInfo.org Offers Osteoporosis Awareness and Prevention Resources for Patients
Newswise· 3 days agoFrom articles about bone health basics to osteoporosis prevention and treatment options, OrthoInfo...
The Bone Health and Osteoporosis Foundation Celebrates May's Osteoporosis Awareness and Prevention...
WPRI Providence· 4 days agoThis Osteoporosis Awareness and Prevention Month is particularly significant for the Bone Health and Osteoporosis Foundation (BHOF) as it celebrates its ...
This Gave Me Osteoporosis At 32 & Here's What I Wish People Knew
MindBodyGreen· 23 hours agoWhile some health issues are visible to the outside world, many people face chronic conditions that...
Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Investor's Business Daily· 2 days agoAdjusted earnings slipped 1% to $3.96 per share, coming in above expectations for $3.88, according...
Big Pharma Has Captured Osteoporosis
Mercola· 2 days agoThe sales funnel concept is crucial to understanding the modern medical industry. The second funnel involves framing preventative medicine as screening individuals for potential health risks ...
Over 50 and Can't Lose Weight? What to Know About Sarcopenia + How to Fix It With Protein
Woman's World via Yahoo News· 2 days agoSnack Top 1 small bowl of Greek yogurt with 1⁄2 cup of fruit or any variety protein bar with at...
Amgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Investor's Business Daily· 2 days agoThe company didn't provide any numbers from its study of MariTide in adults with obesity. This puts Amgen on track to potentially rival blockbuster weight-loss drugs from Eli Lilly (LLY) and ...
People with acute calcium pyrophosphate face doubled risk for fracture
Medical Xpress· 6 days agoFracture risk is nearly doubled in individuals with acute calcium pyrophosphate (CPP) crystal...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
AOL· 5 days agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on Tuesday with Amgen Inc (NASDAQ:AMGN) to resolve all patent litigation related to its U.S. denosumab ...
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation
Morningstar· 5 days agoThe Swiss pharmaceutical company didn't disclose any terms of the...Food and Drug Administration approval for Wyost and Jubbonti--the first denosumab biosimilars to treat skeletal-related events ...